ArticleStem cell research & therapy2020

CRISPR-mediated gene modification of hematopoietic stem cells with beta-thalassemia IVS-1-110 mutation.

Hala Gabr et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.